baber/WOPTO huggingface dataset:
Patent AT-E138468-T1 (AT)
Inventor: BEGEY GEORGES
IPC: F24D19/02
Filed: 1992-07-15
Granted: 1996-06-15
Abstract: The invention relates to a radiator made up of identical or similar heating elements, through which a heating fluid circulates, and making it possible to adapt its outer dimensions by juxtaposition of the said elements. In accordance with the invention, each heating element forms a module (100, 101, 102, 103) comprising : a square or rectangular body (200) having, on the inside, at least one internal hydraulic circuit (201) with parallel columns (202), hydraulic connection means (205) for fluidally joining two modules juxtaposed in a common plane, mechanical assembly means (210, 211) for mechanically coupling the juxtaposed modules; the dimensions of each module are furthermore chosen in such a way that the adjacent hydraulic connection means (205) of two juxtaposed modules are spaced apart by a fixed distance (d1) which also corresponds to the distance separating two adjacent hydraulic connection means (205) of the same module. Application in particular to the modular production of modular cast iron radiators, capable of being installed in situ with the desired geometry. <IMAGE>
Patent AT-E142220-T1 (AT)
Inventor: HAMILTON GREG SCOTT
IPC: A61P25/04
Filed: 1991-12-04
Granted: 1996-09-15
Abstract: An unexpectedly more potent isomer of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid, a known excitatory amino acid antagonist, pharmaceutical compositions including this isomer and methods of using this isomer to antagonize excitatory amino acid receptors.
Patent AT-E176167-T1 (AT)
Inventor: GREGORY KENTON W
IPC: A61B17/00
Filed: 1991-10-18
Granted: 1999-02-15
Abstract: A method for preventing platelet adhesion to a vascular surface in a mammal, which includes irradiating the vascular surface with a pulse of laser energy having a pulse duration less than the thermal relaxation time of the irradiated vascular surface, wherein lasar energy is delivered to said vascular surface via radiographic contrast material.
Patent AT-E114953-T1 (AT)
Inventor: GUSTAVSON LARRY J
IPC: A61K39/00
Filed: 1991-04-12
Granted: 1994-12-15
Abstract: A prosthetic part for use as an orthopedic implant has a base member defining an outer surface for implantation adjacent a prepared bone surface. The outer surface includes a recessed area having a predetermined shape and depth. A first rigid plate having this predetermined shape and having a plurality of elongated slots formed therein is fixedly attached within the recesssed area of the base member. A second rigid plate also having the same predetermined shape as the recess and also having a plurality of elongated slots formed therein is attached to the first rigid plate. The elongated slots of the second plate are angularly offset with respect to the elongated slots in the first plate to produce a controlled porosity. The thicknesses of the first and second plates are predetermined so that the outer surface of the second plate is continuous with the non-recessed outer surface of the base member.
Patent AT-E122473-T1 (AT)
Inventor: HAMBLEN DAVID P
IPC: G02B9/00
Filed: 1991-12-06
Granted: 1995-05-15
Abstract: The present invention relates to an optical element and catadioptric optical systems using the optical element. The optical element has a spherical surface with a reflective layer formed on at least a portion of the surface, and is formed of a radiant energy transmitting material having a radial gradient index of refraction. The catadioptric optical systems include at least two optical elements at least one of which is refractive, and at least one of which has a gradient index therein. One optical system includes first and second optical elements disposed sequentially along a longitudinal axis of the system. The second optical element is the optical element with the gradient index. The first optical element is formed of a homogeneous light transmitting material and includes a spherical surface, and a reflective layer formed on a central portion of one of the spherical surface.
Patent AT-E159033-T1 (AT)
Inventor: HUC ALAIN
IPC: A61K8/72
Filed: 1992-01-22
Granted: 1997-10-15
Abstract: The invention relates to a polyose/fatty acid complex product. This complex product is the reaction product of at least one polyose with at least one fatty acid, in particular in the form of a halide or the anhydride. The fatty acid can be saturated or unsaturated and can comprise from 8 to 28 carbon atoms. This complex product has a high moisturizing capacity and, surprisingly, an emulsifying capacity and can be used to prepare valuable cosmetic or pharmaceutical compositions.
Patent AT-E199746-T1 (AT)
Inventor: KINZLER KENNETH W
IPC: C07K14/47
Filed: 1992-01-16
Granted: 2001-03-15
Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
Patent AT-E128868-T1 (AT)
Inventor: KOENIG BERNHARD
IPC: A61P31/12
Filed: 1992-03-13
Granted: 1995-10-15
Abstract: The invention concerns the use of oxazolo-[2,3-a]isoindole and iminazo[2,1-a]isoindole derivatives as antiviral drugs, as well as optically active derivatives, new oxazolo-[2,3-a]isoindole derivatives, a method for preparing them and drugs containing these compounds. In particular, the subject matter of the invention is the use of oxazolo-[2,3-a]isoindole and imidazo[2,1-a]isoindole derivatives of general formula (I) to produce antiviral drugs. In formula (I), X stands for an oxygen atom or a sulphur atom, the imino group =NH or a =N-C1?-C5? alkylimino group, Y stands for an oxygen atom or the group NR?7, wherein R?7 is a hydrogen atom or a C1?-C6? alkyl residue or a C1?-C6? acyl residue, R is a hydrogen atom, a straight-chain or branched, saturated or unsaturated aliphataic residue containing 1-9 carbon atoms, possibly substituted by phenyl, or a phenyl ring possibly substituted one or more times, or a carbocyclic or heterocyclic ring, R?1 and R?2 stand for a hydrogen atom, a straight-chain or branched, saturated or unsaturated aliphatic residue with 1 to 6 carbon atoms, R?3-R?6 stand for hydrogen, C1?-C6? alkyl, C1?-C6? alkoxy, C1?-C6? alkylmercapto, amino, C1?-C6? alkylamino, di-C1?-C6? alkylamino, halogen, cyano, hydroxy, carboxy, aminocarbonyl, substituted aminocarbonyl or C1?-C6? alkoxycarbonyl. The invention also concerns their tautomers, enantiomers, diastereomers and physiologically acceptable salts.
Patent AT-E126974-T1 (AT)
Inventor: GIRARDELLI HELMUT
IPC: A43B5/04
Filed: 1992-03-20
Granted: 1995-09-15
Abstract: A ski boot with a sole plate (1) and a shell (2, 3, 4, 12, 26, 27, 28, 39, 40, 41) and a support (9) securable above the ankle to the lower leg which is secured to the sole plate via a yoke (5), whereby the support takes the form of a fastenable sleeve (9) acting together with at least one shell section (12, 26), said sleeve's being secured to the yoke (5), preferably at a point between two fasteners (11a, 11b) of the sleeve (9), via a bracket (7) surrounding about half of the circumference of the lower leg.
Patent AT-E146448-T1 (AT)
Inventor: NAGEL ALWIN
IPC: C04B35/58
Filed: 1992-04-15
Granted: 1997-01-15
Abstract: A bearer for the screen or felt of a paper machine consists of one or more combined sintered mouldings based on silicon nitride, the main structural phase of which is needle-like  beta  silicon nitride grains which are surrounded by an amorphous or partly crystalline grain boundary phase of a rare earth/aluminium silicate phase, in which the cationic impurity content of the sintered moulding is less than 1 wt % and all parts by weight are made up to 100 wt % and said grains have an average diameter of no more than 1.5  mu m. The sintered mouldings have a bend strength of at least 500 MPa and a Vickers hardness HV 0.5 of 1,400 to 1,700.
Patent AT-E145404-T1 (AT)
Inventor: FRENCH JAMES CLARK
IPC: B01J41/20
Filed: 1992-07-16
Granted: 1996-12-15
Abstract: A process for purifying pentostatin from a crude fermentation beer comprising the steps of 1) applying the fermentation beer to a strong cation exchange resin; 2) eluting with ammonium hydroxide; 3) concentrating the eluate; 4) applying the concentrated eluate to a strongly basic anion exchange resin charged with borate ion; 5) eluting with water; 6) applying this eluate to styrene-divinylbenzene beads prewashed with ethanol; 7) eluting the beads with water; and 8) recrysllyzing the pentostatin from water and methanol to yield a product that is greater than 99.7% pure.
Patent AT-E130038-T1 (AT)
Inventor: BAYER THOMAS
IPC: C12P35/00
Filed: 1992-08-08
Granted: 1995-11-15
Abstract: Described is a method for the fermentative production of cephalosporin C, the fermentation solution being filtered during fermentation through a cross-flow filtration system. The filtrate obtained from the fermenter can be used again.
Patent AT-E151114-T1 (AT)
Inventor: WAGNER ROBERT E JR
IPC: C12Q1/68
Filed: 1992-07-17
Granted: 1997-04-15
Abstract: A method for detecting mutations, such as a single base change or an addition or deletion of about one to four base pairs, is based on the use of a DNA mismatch-binding protein, such as MutS, which binds to a nucleic acid hybrid having a single base mismatch or unpaired base or bases, thereby allowing the detection of mutations involving as little as one base change in a nucleotide sequence. Such a method is useful for diagnosing a variety of important disease states or susceptibilities, for example, detecting the presence of a mutated oncogen. The method shares the efficiency advantages of PCR-based methods but is much simpler and cheaper to perform. Also provided is a kit useful for practicing the method of the present invention.
Patent AT-E173295-T1 (AT)
Inventor: GODOWSKI PAUL J
IPC: C12N15/09
Filed: 1992-08-03
Granted: 1998-11-15
Abstract: A method of inducing gene expression in a mammalian cell or an intact mammal comprising contacting an ecdysteroid, such as muristerone A, with an ecdysteroid receptor polypeptide within a mammalian cell, wherein said mammalian cell further contains a DNA binding sequence for said ecdysteroid receptor when in combination with its ligand, such as muristerone A, thereby resulting in gene expression.
Patent AT-E144144-T1 (AT)
Inventor: COLLINS JAMES EDWARD
IPC: G01N33/569
Filed: 1992-08-17
Granted: 1996-11-15
Abstract: The method of diagnosis of Mystery Swine Disease (MSD) is carried out with polyclonal or monoclonal antibody sera. Either the antibody sera or the biopsied tissue homogenate may be immobilized by contact by contact with a polystyrene surface or with a surface of another polymer for immobilizing protein. Preferably the monoclonal antibody is produced by a murine derived hybrid cell line wherein the antibody is an IgG or IgM type immunoglobulin. Example monoclonal antibodies to the infectious agent for SIRS are monoclonal antibody SDOW 12 and SDOW 17.
Patent AT-E124370-T1 (AT)
Inventor: HABERL WOLF-DIETER
IPC: B65D88/16
Filed: 1992-12-10
Granted: 1995-07-15
Abstract: Described is a transport container (1) made of textile fabric, the container walls (7, 8, 9, 10) being made from at least one strip of fabric (7, 8, 9, 10) and having at least one longitudinal seam (11, 12). The container is characterized in that the single longitudinal seam (21) or the several longitudinal seams (11, 12) are flush-sewn. The flush-sewn seams (11, 12, 21) are preferably produced using chain stitches.
Patent AT-E136316-T1 (AT)
Inventor: WEBER WILHELM DR
IPC: C08G77/06
Filed: 1993-02-22
Granted: 1996-04-15
Abstract: The invention relates to a process for the preparation of triorganyloxysilyl- or organodiorganyloxysilyl-terminated poly(diorganosiloxane) by reacting  alpha , omega -dihydroxypoly(diorganosiloxane) with tetraorganyloxysilane or organotriorganyloxysilane in the presence of alkali metal hydroxides, alkali metal alkoxides (alcoholates) and/or alkali metal silanolates in catalytically effective amounts, the reaction being carried out in the additional presence of at least one alkali metal salt which is soluble in the reaction system.
Patent AT-E154875-T1 (AT)
Inventor: POHL YANGO
IPC: A61C5/00
Filed: 1993-03-05
Granted: 1997-07-15
Abstract: In apicectomies carried out after cutting out a bone cavity it is very often necessary to conduct a root treatment. The corresponding fillings must be performed under dry conditions, so that the exposed bone surface must be separated from the resection surface in order to avoid blood being able to pass into the root region to be filled, on the one hand, and any reagents that may be necessary (e.g. for irrigation of the root canal) and solid particles of matter being able to reach the bone cavity, on the other hand. For this purpose, a means is provided which permits complete lining of the bone cavity and separates the material of the latter from the root region to be filled. At the same time, the lining 10 comprises two layers 11 and 12 of different, mutually complementing functions. The lining 10 is pressed into the bone cavity 3 with an appropriate tool and is thereby simultaneously deformed and adapted to the surface 4 thereof.   <IMAGE>
Patent AT-E141967-T1 (AT)
Inventor: OHM HEINZ-JOSEF
IPC: D06F57/04
Filed: 1993-11-25
Granted: 1996-09-15
Abstract: Umbrella-type clothes drier with supporting arms consisting of a box profile open on one side, for holding a washing line divided into individual line rings which are held in slides at the corners via clips, and segmental covers with a line passage for closing the supporting arms, the box profile being provided, for the sliding reception of the slides (7), with holding strips (17) and the segmental covers (19, 37, 39) being provided with holding grooves (18) for releasable interlocking. <IMAGE>
Patent AT-E152686-T1 (AT)
Inventor: CATER MIRO S
IPC: B05B7/02
Filed: 1993-08-24
Granted: 1997-05-15
Abstract: Apparatus (1) for delivering water based formulations as an aerosol spray provides for quantities of liquid and air to be pressurised by pump action in separate chambers (61,59) defined by integrally formed cylinders (14,10). Liquid is dispensed through an orifice (69) via a dispensing channel (67) which in one embodiment is purged during a terminal part of the actuating stroke by the release of air through the dispensing channel. In a second embodiment air and liquid are mixed during the actuating stroke so as to be dispensed together and during a return stroke air is sucked through the dispensing channel to remove residual liquid. The air purging action prevents the build-up of deposits in the dispensing channel and orifice. <IMAGE>
Patent AT-E134621-T1 (AT)
Inventor: AXELSSON OSKAR
IPC: A61K31/415
Filed: 1993-03-24
Granted: 1996-03-15
Abstract: The present invention discloses compounds of the formula <CHEM>  wherein     X is C or N;     Y is C or N;     R<1><1> is hydrogen, hydroxy, or alkoxy; R<1><2> and R<1><3> are each independently hydrogen; halogen; CF3; CN; OH; alkyl; cycloalkyl; cycloalkylalkyl; alkenyl; alkynyl; alkoxy; phenylalkyl; amino; nitro; sulphamoyl; pipiridyl; pyrrolidinyl; acyl; CO2H; CO2-alkyl; CO-amino; NH-CO-alkyl; phenylsulphonyl which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; phenyloxy which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; phenylamino which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; or aryl which may be substituted one or more times with halogen, CF3, CN, OH, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, phenoxy, phenylalkyl, amino, nitro, sulphamoyl, pipiridyl, pyrrolidinyl, CO2H, CO2-alkyl, CO-amino, or NH-CO-alkyl; and R<4>, R<5>, R<6> and R<7> are each independently hydrogen; halogen; amino; nitro; CN; CF3; COOH; COO-alkyl; alkyl; acyl; alkoxy; -(CH2)n,-OH wherein n is 0, 1,2, or 3; -(CH2)m-O-alkyl wherein m is 0, 1,2, or 3; -(CH2)o-O-acyl wherein o is 0, 1,2, or 3; and that if X is N then R<4> is absent and that if Y is N then R<7> is absent;  or a pharmaceutically-acceptable addition salt thereof The compounds are useful as pharmaceuticals, for example, in the treatment of stroke, ischemia, anoxia, migraine and psychosis.
Patent AT-E175978-T1 (AT)
Inventor: PELL JENNIFER MARGARET
IPC: A61K38/00
Filed: 1993-08-20
Granted: 1999-02-15
Abstract: Antibodies and other specific binding molecules which bind to insulin-like growth factor-I (IGF-I), particularly the 1-17, 18-21, 22-37, 45-53, 54-60, 59-70 or, especially, the 36-44 region, potentiate or enhance its activity. The antibodies may be generated (in situ) by administering an appropriately antigenic molecule. IGF-I potentiation is useful in a wide range of clinical conditions.
Patent AT-E173736-T1 (AT)
Inventor: COTTENS SYLVAIN
IPC: A61K31/00
Filed: 1993-09-24
Granted: 1998-12-15
Abstract: O-allylated rapamycin derivs. of formula (I) are new. X = (H,H) or O; Y = (H, OH) or O; R1 and R2 = each H, alkyl, thioalkyl, arylalkyl, hydroxyalkyl, dihydroxyalkyl, hydroxyalkylarylalkyl, dihydroxyalkylaralkyl, alkoxyalkyl, acyloxyalkyl, aminoalkyl, alkylaminoalkyl, alkoxycarbonylamino-alkyl, acylaminoalkyl, arylosulphonamido-alkyl, allyl, dihydroxyalkylallyl, dioxolanyl-allyl, carbalkoxyallyl or (R3)3Si; R3 = each H, Me, Et, i-Pr, t-Bu or Ph; R4 = Me; or R4 and R1 together form 2-6C alkylene; alk- or alkyl refer to 1-6C alkyl, branched or linear, esp. 1-3C alkyl, in which the carbon chain is opt. interrupted by an ether linkage; provided that T1 and R2 are not both it; and provided that when R1 is carboxyalkyl or (R3)3Si, X and Y are not both O. Dose is 0.05-10 mg/kg p.o. or 0.01-5 mg/kg. i.r.
Patent AT-E204491-T1 (AT)
Inventor: KREBS CHRISTIAN
IPC: A61M16/08
Filed: 1994-04-09
Granted: 2001-09-15
Abstract: An apparatus for the controlled dosage of NO to the air supply of patients with ARDS or similar disorders, essentially comprises a ventilator (1), an NO metering vessel (3), a metering unit (4), an analyser (2) for determining the concentration of NO in the patient's air supply and a control unit (6a) acting upon the metering unit. In order to achieve interference-free functioning of the apparatus in continuous operation and a quick reaction to changes in the NO concentration, a dehumidifier (23) and a measuring gas pump (20) are located in the connection line between the analyser and the ventilator. Preferably, an NO limit value monitoring unit (18) which acts upon the metering unit and is connected to the analyser, is provided. Furthermore, a monitoring and control unit (6b) advantageously adjusts the NO to be metered by determining the volume flows of respiration gas and NO with due consideration of the NO analysis value. <IMAGE>
Patent AT-E150377-T1 (AT)
Inventor: CORTI MARCO
IPC: B41F35/06
Filed: 1994-07-18
Granted: 1997-04-15
Abstract: The device according to the invention comprises a presser which acts on the printing cylinder (R) with the interposition of a strong membrane (4) of elastomeric material, securely fixed, at least with its longitudinal edges, to corresponding supports of the presser bar (1). During the active phase of the operation of the presser, the membrane (4) is subjected to composite compressive, bending, tensile and other stresses, as a result of which the membrane acts on the printing cylinder (R) with a distributed pressure. On the cessation of contact with the cylinder (R), the membrane (4) returns by its own elasticity to its extended resting state. In combination with the elasticity of the membrane, advantage is preferably taken of the effect of pneumatic counter-pressure (110) to which the membrane is subjected when it is mounted with an air-tight seal on a corresponding chamber (3) of the presser bar (1). <IMAGE>
Patent AT-E141128-T1 (AT)
Inventor: BRAUN HANS DIPL-WI-ING
IPC: A01K31/08
Filed: 1994-09-07
Granted: 1996-08-15
Abstract: In order that a buyer can assemble a dismantleable cage of the generic type in a simple manner without the aid of special tools, the (usually) four side walls (2 to 5) are connected to one another via profile rails (7 to 10). The profile rails are divided in two in the longitudinal direction and comprise an outer profile-rail part (16) and an inner profile-rail part (17). The two are held together in captive fashion via rotary parts (22). In the case of a variant, expansion springs (35, 36) ensure that the profile-rail parts (16, 17) are kept apart in the loose state in order to provide the widest possible plug-in gaps (33) for the wire-grid border regions (19, 20) which are to be plugged in. Rotation of the rotary parts (20), for example through approximately 90 DEG , brings the inner profile-rail part (17) closer to the outer profile-rail part (16), the wire-grid border regions (19, 20) being clamped in at the same time. <IMAGE>
Patent AT-E173142-T1 (AT)
Inventor: GRUND GARY H
IPC: E04B2/74
Filed: 1990-02-07
Granted: 1998-11-15
Abstract: A freestanding modular furniture arrangement is provided to create workstations in open office plans, and other similar applications. Each furniture unit includes a worksurface (5) with cutouts (6) having caps (77) in the rear corners to mount overhead cabinets (7), privacy screens (8), and other furniture accessories. A mounting rail (12) extends continuously along the rearward edge of each work-surface, and is capable of removably supporting therein a plurality of different amenities, such as bookshelves, CRT stands, fans, task lamps, etc., so as to permit a worker to personalize his or her own workstation. A removable stanchion (171) permits certain convertible amenities to be supported either freestanding on the worksurface, or along the rear of the worksurface on the mounting rail. An L-shaped intermediate leg (14) is available to support the worksurface in a cantilevered fashion to facilitate unfettered task chair movement along the forward edge of the worksurface. <IMAGE>
Patent AT-E243712-T1 (AT)
Inventor: ANDRESS DENNIS L
IPC: C12N15/09
Filed: 1993-10-29
Granted: 2003-07-15
Abstract: Methods for stimulating osteogenesis using C-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) compounds and derivatives thereof are described. The IGFBP-5 polypeptides used in the methods are mitogenic and can be combined in compositions with insulin-like growth factor (IGF).
Patent AT-E202269-T1 (AT)
Inventor: DOYLE KELVIN CONRAD
IPC: A61F5/02
Filed: 1994-02-16
Granted: 2001-07-15
Abstract: A limb protector to protect a knee or elbow joint in active sports and also for use after the joint has been injured has upper and lower curved, rigid, resilient supports which can be attached to an arm or leg above and below the knee or elbow, is arranged so that the upper and lower supports can rotate relative to each other, by an adjustable amount, in a horizontal plane and can also hinge relative to each other in a vertical plane.
Patent AT-E170841-T1 (AT)
Inventor: ASHWELL MARK ANTONY
IPC: A61K31/44
Filed: 1994-03-17
Granted: 1998-09-15
Abstract: PCT No. PCT/GB94/00539 Sec. 371 Date May 24, 1995 Sec. 102(e) Date May 24, 1995 PCT Filed Mar. 17, 1994 PCT Pub. No. WO94/21610 PCT Pub. Date Sep. 29, 1994Piperazine derivatives of formula (I) and their salts are 5-HT1A binding agents and may be used, for example, as anxiolytics. In the formula, R, R2 and R4 are hydrogen or lower alkyl, R1 is mono- or bicyclic aryl or heteroaryl, R3 is lower alkyl or cycloalkyl, A is an alkylene chain and X is -CO-. -CR5OH- (where R5 is hydrogen, lower alkyl or cycloalkyl), -S-, -SO- or -SO2- or X can also be -(CH2)n- (where n is 0, 1 or 2) when R3 is cycloalkyl.    <IMAGE>  (I)
Patent AT-E168378-T1 (AT)
Inventor: HUDLICKY TOMAS
IPC: C07D493/04
Filed: 1994-05-05
Granted: 1998-08-15
Abstract: There are described improved processes for the synthesis of a desired lactone useful as a synthon, the improved processes comprising oxidizing a protected arene diol with permanganate and periodate or subjecting a substituted epoxydiol to periodate oxidation to yield the desired lactone.